Chronic viral coinfections differentially affect the likelihood of developing long COVID-Reference-Cited by-同舟云学术

Chronic viral coinfections differentially affect the likelihood of developing long COVID

Published:2023-02-01 Issue:3 Volume:133 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Peluso Michael J.^ORCID,Deveau Tyler-Marie,Munter Sadie E.,Ryder Dylan,Buck Amanda,Beck-Engeser Gabriele,Chan Fay,Lu Scott,Goldberg Sarah A.^ORCID,Hoh Rebecca^ORCID,Tai Viva,Torres Leonel,Iyer Nikita S.^ORCID,Deswal Monika^ORCID,Ngo Lynn H.,Buitrago Melissa,Rodriguez Antonio,Chen Jessica Y.^ORCID,Yee Brandon C.^ORCID,Chenna Ahmed^ORCID,Winslow John W.^ORCID,Petropoulos Christos J.^ORCID,Deitchman Amelia N.^ORCID,Hellmuth Joanna,Spinelli Matthew A.^ORCID,Durstenfeld Matthew S.^ORCID,Hsue Priscilla Y.,Kelly J. Daniel,Martin Jeffrey N.^ORCID,Deeks Steven G.^ORCID,Hunt Peter W.^ORCID,Henrich Timothy J.^ORCID

Funder

National Institutes of Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/163669/files/pdf

Reference63 articles.

1. Post-acute COVID-19 syndrome

2. WHO. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 Updated October 6, 2021. Accessed November 30, 2022

3. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

4. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection;Phetsouphanh;Nat Immunol,2022

5. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latent viral infections as neglected risk factors for long COVID;The Lancet Global Health;2024-02

2. Immune damage in Long Covid;Science;2024-01-19

3. MicroRNA-focused CRISPR/Cas9 Screen Identifies miR-142 as a Key Regulator of Epstein-Barr Virus Reactivation;2024-01-15

4. Case report: Enhancing prognosis in severe COVID-19 through human herpes virus coinfection treatment strategies;Frontiers in Cellular and Infection Microbiology;2024-01-10

5. Visual analysis of hotspots and trends in long COVID research based on bibliometric;Heliyon;2024-01